- Home
- AZUL vs NBTX Comparison
AZUL vs NBTX Comparison
Compare AZUL & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZUL
- NBTX
- Stock Information
- Founded
- AZUL 2008
- NBTX 2003
- Country
- AZUL Brazil
- NBTX France
- Employees
- AZUL N/A
- NBTX N/A
- Industry
- AZUL Air Freight/Delivery Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- AZUL Consumer Discretionary
- NBTX Health Care
- Exchange
- AZUL Nasdaq
- NBTX Nasdaq
- Market Cap
- AZUL 214.5M
- NBTX 178.7M
- IPO Year
- AZUL 2017
- NBTX 2020
- Fundamental
- Price
- AZUL $1.66
- NBTX $3.58
- Analyst Decision
- AZUL Hold
- NBTX Strong Buy
- Analyst Count
- AZUL 9
- NBTX 1
- Target Price
- AZUL $5.36
- NBTX $12.00
- AVG Volume (30 Days)
- AZUL 850.4K
- NBTX 13.1K
- Earning Date
- AZUL 05-12-2025
- NBTX 04-23-2025
- Dividend Yield
- AZUL N/A
- NBTX N/A
- EPS Growth
- AZUL N/A
- NBTX N/A
- EPS
- AZUL N/A
- NBTX N/A
- Revenue
- AZUL $3,157,077,406.00
- NBTX $45,220,186.00
- Revenue This Year
- AZUL N/A
- NBTX N/A
- Revenue Next Year
- AZUL $6.53
- NBTX N/A
- P/E Ratio
- AZUL N/A
- NBTX N/A
- Revenue Growth
- AZUL 5.24
- NBTX 526.17
- 52 Week Low
- AZUL $1.57
- NBTX $2.76
- 52 Week High
- AZUL $8.24
- NBTX $7.51
- Technical
- Relative Strength Index (RSI)
- AZUL 40.28
- NBTX 51.20
- Support Level
- AZUL $1.75
- NBTX $3.32
- Resistance Level
- AZUL $1.82
- NBTX $3.77
- Average True Range (ATR)
- AZUL 0.10
- NBTX 0.19
- MACD
- AZUL -0.00
- NBTX 0.01
- Stochastic Oscillator
- AZUL 13.33
- NBTX 52.58
About AZUL Azul S.A. (each representing three preferred shares)
Azul SA is involved in the operation of regular and non-regular airline passenger services, cargo or mail, passenger charter, provision of maintenance and hangarage services for aircraft, engines, parts and pieces, aircraft acquisition and lease, development of frequent-flyer programs, development of related activities and equity holding in other companies. The Company considers that it has a single reportable segment which is air transport.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.